Baaten B - Search Results

1

Intranasal immunisation with inactivated RSV and bacterial adjuvants induces mucosal protection and abrogates eosinophilia upon challenge.

Etchart N, Baaten B, Andersen SR, Hyland L, Wong SY, Hou S. Etchart N, et al. Among authors: baaten b. Eur J Immunol. 2006 May;36(5):1136-44. doi: 10.1002/eji.200535493. Eur J Immunol. 2006. PMID: 16619288 Free article.

2

Nasal mucosal administration of chitin microparticles boosts innate immunity against influenza A virus in the local pulmonary tissue.

Baaten BJ, Clarke B, Strong P, Hou S. Baaten BJ, et al. Vaccine. 2010 Jun 7;28(25):4130-7. doi: 10.1016/j.vaccine.2010.04.026. Epub 2010 Apr 28. Vaccine. 2010. PMID: 20433805

3

Bone marrow immunosuppression in Salmonella-infected mice is prolonged following influenza virus infection.

Hyland L, Villarreal-Ramos B, Clarke B, Baaten B, Hou S. Hyland L, et al. Among authors: baaten b. Exp Hematol. 2005 Dec;33(12):1477-85. doi: 10.1016/j.exphem.2005.09.005. Exp Hematol. 2005. PMID: 16338490 Free article.

4

Early replication in pulmonary B cells after infection with Marek's disease herpesvirus by the respiratory route.

Baaten BJ, Staines KA, Smith LP, Skinner H, Davison TF, Butter C. Baaten BJ, et al. Viral Immunol. 2009 Dec;22(6):431-44. doi: 10.1089/vim.2009.0047. Viral Immunol. 2009. PMID: 19951180

5

Study of host-pathogen interactions to identify sustainable vaccine strategies to Marek's disease.

Baaten BJ, Butter C, Davison TF. Baaten BJ, et al. Vet Immunol Immunopathol. 2004 Aug;100(3-4):165-77. doi: 10.1016/j.vetimm.2004.04.009. Vet Immunol Immunopathol. 2004. PMID: 15207454 Review.

6

Protection from infectious bursal disease virus (IBDV)-induced immunosuppression by immunization with a fowlpox recombinant containing IBDV-VP2.

Butter C, Sturman TD, Baaten BJ, Davison TF. Butter C, et al. Among authors: baaten bj. Avian Pathol. 2003 Dec;32(6):597-604. doi: 10.1080/03079450310001610686. Avian Pathol. 2003. PMID: 14676010

7

Route of challenge is critical in determining the clinical outcome of infection with a very virulent oncogenic herpesvirus, Marek's disease virus.

Butter C, Staines K, Baaten B, Smith L, Davison TF. Butter C, et al. Among authors: baaten b. Avian Pathol. 2007 Apr;36(2):93-9. doi: 10.1080/03079450601156075. Avian Pathol. 2007. PMID: 17479368

8

Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30).

Burgess SC, Young JR, Baaten BJ, Hunt L, Ross LN, Parcells MS, Kumar PM, Tregaskes CA, Lee LF, Davison TF. Burgess SC, et al. Among authors: baaten bj. Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13879-84. doi: 10.1073/pnas.0305789101. Epub 2004 Sep 8. Proc Natl Acad Sci U S A. 2004. PMID: 15356338 Free PMC article.

9

Intravenous treatment with liposome-encapsulated dichloromethylene bisphosphonate (Cl2MBP) suppresses nitric oxide production and reduces genetic resistance to Marek's disease.

Rivas C, Djeraba A, Musset E, van Rooijen N, Baaten B, Quéré P. Rivas C, et al. Among authors: baaten b. Avian Pathol. 2003 Apr;32(2):139-49. doi: 10.1080/030794502100007163. Avian Pathol. 2003. PMID: 12745367

10

Matrix metalloprotease 9 mediates neutrophil migration into the airways in response to influenza virus-induced toll-like receptor signaling.

Bradley LM, Douglass MF, Chatterjee D, Akira S, Baaten BJ. Bradley LM, et al. Among authors: baaten bj. PLoS Pathog. 2012;8(4):e1002641. doi: 10.1371/journal.ppat.1002641. Epub 2012 Apr 5. PLoS Pathog. 2012. PMID: 22496659 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters